The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: a Danish population-based cohort study by Petersen, MB, Hansen, RL, Egeberg, A, Jørgensen, TS, Merola, JF, Coates, LC, Kristensen, LE

Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomis... by Tarp, S, Jørgensen, TS, Furst, DE, Dossing, A, Taylor, PC, Choy, EH, Suarez-Almazor, ME, Lyddiatt, A, Kristensen, LE, Bliddal, H, Christensen, R

In psoriatic arthritis fatigue is driven by inflammation, disease duration, and chronic pain: An observational DANBIO registry study by Skougaard, M, Jørgensen, TS, Rifbjerg-Madsen, S, Coates, LC, Egeberg, A, Amris, K, Dreyer, L, Højgaard, P, Guldberg-Møller, J, Merola, JF, Frederiksen, P, Gudbergsen, H, Kristensen, LE

Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study by Skougaard, M, Jørgensen, TS, Jensen, MJ, Ballegaard, C, Guldberg-Møller, J, Egeberg, A, Christensen, R, Benzin, P, Stisen, ZR, Merola, JF, Coates, LC, Strand, V, Mease, P, Kristensen, LE